A
Alan R. Zinsmeister
Researcher at University of Rochester
Publications - 286
Citations - 20878
Alan R. Zinsmeister is an academic researcher from University of Rochester. The author has contributed to research in topics: Population & Irritable bowel syndrome. The author has an hindex of 80, co-authored 286 publications receiving 19885 citations. Previous affiliations of Alan R. Zinsmeister include University of Sydney.
Papers
More filters
Journal ArticleDOI
Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues.
TL;DR: Eos inophilic gastroenteritis should be considered in the differential diagnosis of unexplained gastrointestinal symptoms even in the absence of peripheral eosinophilia, according to the clinicopathological spectrum.
Journal ArticleDOI
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
Edward V. Loftus,Gavin C. Harewood,Conor G. Loftus,William J. Tremaine,William S. Harmsen,Alan R. Zinsmeister,Debra A. Jewell,William J. Sandborn +7 more
TL;DR: Colorectal neoplasia develops in a substantial fraction and overall survival is worse and PSC-IBD may represent a distinct IBD phenotype.
Journal ArticleDOI
Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.
Edward V. Loftus,Marc D. Silverstein,Marc D. Silverstein,William J. Sandborn,William J. Tremaine,W. Scott Harmsen,Alan R. Zinsmeister +6 more
TL;DR: The incidence and prevalence of Crohn's disease in Olmsted County, Minnesota has stabilized since the 1970s at a rate higher than that seen previously, and overall survival is slightly decreased.
Journal ArticleDOI
The epidemiology of community-acquired Clostridium difficile infection: a population-based study
Sahil Khanna,Darrell S. Pardi,Scott Aronson,Scott Aronson,Patricia P. Kammer,Robert Orenstein,Jennifer L. St. Sauver,W. Scott Harmsen,Alan R. Zinsmeister +8 more
TL;DR: In this population-based cohort, a significant proportion of cases of CDI occurred in the community, and patients were younger and had less severe infection than those with hospital-acquired infection.
Journal ArticleDOI
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
James J. Maciejko,David R. Holmes,Bruce A. Kottke,Alan R. Zinsmeister,Dac M. Dinh,Simon J.T. Mao +5 more
TL;DR: It is concluded that apolipoprotein A-I by itself is more useful than HDL cholesterol for identifying patients with coronary-artery disease.